Blue Eagle Lithium
High Times
Home > Boards > US OTC > Medical - Equipment >

Repro-Med Systems (REPR)

Add REPR Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 10/17/2018 5:27:30 AM - Followers: 76 - Board type: Free - Posts Today: 0

Repro-Med Systems, Inc. (dba RMS Medical Products) engages in the design, manufacture, and marketing of proprietary medical devices primarily for emergency medical applications and ambulatory infusion therapy. It offers the FREEDOM60, an infusion system that enables administration of primary immune deficiency by injecting immune globulin under the skin for the home health care industry and patient emergency transportation. The company's FREEDOM60 is also used for treating thalissemia with the drug desferal; for pain control, primarily post-operative epidural pain administration; and for chemotherapy in Europe. Repro-Med also manufactures the FREEDOM60-FM, which contains an electronic flow monitor system that provides occlusion and end of infusion alarm for nursing homes, hospitals, and pediatric ambulatory applications; and the RES-Q-VAC Emergency Airway Suction System, a hand-operated suction device that removes fluids from a patient's airway by attaching the RES-Q-VAC pump to various proprietary sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. In addition, the company offers DENTAL-EVAC for emergency back up suction during a procedure to oral surgeons; and RES-Q-VAC for military situations, such as exposure to chemical weapons of mass destruction. Repro-Med sells its products directly, as well as through a network of domestic and international distributors, and medical device distributors.

Web Site

Main Products

Historical Financials

Quarter    Q1'07(May)    Q2'07(Aug)    Q3'07(Nov)    Q4'07(Feb)     Q1'08(May)    Q2'08(Aug)    Q3'08(Nov)    Q4'08(Feb)    Q1'09(May)   Q2'09(Aug)
Revenue $347,725 $416,009 $457,991 $512,855 $397,417 $605,946 $620,879 $723,436 $699,976 $936,495
Net Income -$207,314 -$89,149 -$67,695 $29,389 -$178,520 $54,367 $61,359 $55,292 $64,784 $275,529

Press Releases
06/11/2007 Higher Medicare Reimbursment for Freedom60 Syringe Infusion Pump -
08/22/2007 Medicare Clarification Reimbursing the Freedom60 with Subcutaneous Immune Globulin - Interview - Required Listening
some tidbits from the interview:

Investment Thesis
1. The company has been hiring like crazy since the middle of last year. This rapid hiring indicates that business is going quite well. Also, I believe that much of this growth has yet to hit the bottom line. As of Feb 2007 they had 17 employees which makes the evidence in the links below look quite bullish.

Picture of hiring sign on building -
Local DD of international expansion and radio advertising -
Currently available positions -
Bookkeeper / Purchasing Associate 4/24/08 -
Customer coordinator posting 10/02/07 -
Assembler hiring posting 08/30/07 -
Assembler hiring posting 7/24/07 -

2. Freedom60 sales have been growing rapidly and I believe will continue to grow rapidly. Here is why:
a. The Freedom60 pump is the most popular pump used for subcutaneous administration of immunoglobulin (SCIG) according to my conversation with CSL Behring who is the maker of the drug used for SCIG. I also verified this with a nurse. The Freedom60 pump is also the least expensive.
b. Vivaglobin® is the first and only immunoglobulin FDA-approved for subcutaneous administration (SCIG). Vivaglobin sales are increasing rapidly according to CSL's financial report.
c. The Freedom60 is the only device approved by Medicare for in-home SCIG treatment. This point was just clarified in August of last year. Also, Medicare reimbursement for the Freedom60 was increased 20 fold in June of 2007.
d. The FREEDOM60 is superior to other pumps for SCIG. Here is what the company says about this in the 10-K: "We have surmised and have recently confirmed anecdotally that the Freedom60 system because of its constant safe pressure design is the ideal technology to infuse this medication regardless of cost. IgG is quite viscous, and the Freedom60 appears to adjust automatically to patient tissue saturation, preventing complications at the administration sites which include pain, swelling, redness and possible tissue damage. Competitive electronic devices, which are also used for this indication, can deliver higher and quite possibly harmful pressures, and will reach occlusion pressures, which will frequently cause the electronic pumps to shut down prior to completing the drug delivery."
e. The most pervasive treatment for Primary Immunity Deficiency right now is IVIG (intravenous). People are switching to SCIG because:
- It is more convenient.
- It costs less.
- There are less adverse reactions.
- Because treatment is generally done weekly instead of monthly the immunity level remains more constant which should help keep the patient more healthy.
f. The company made bullish statements about growing Freedom60 sales in the last 10-Q.
g. According to the immune deficiency organization ( there are more SGIG drugs that are going through trials right now. This should further increase demand for SCIG treatment and Freedom60 sales.

3. They have high gross margins. Last quarter they were 64%. This means that any additional sales rapidly increase earnings.

4. They get a big recurring revenue stream from each Freedom60 that they sell. Annual sales for supplies for the Freedom60 cost on average $252/unit. The list price for the Freedom60 is $399. The revenue information that they put in the 10-K regarding disposable sales indicates that they are thinking big. See the following post for more info:

5. Growing medical businesses are recession proof. I really like businesses like that right now.

More headquarters pics: (11 total)

Blue Eagle Lithium
High Times
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
REPR News: Statement of Changes in Beneficial Ownership (4) 10/16/2018 05:31:47 PM
REPR News: Current Report Filing (8-k) 10/16/2018 05:30:23 PM
REPR News: Statement of Changes in Beneficial Ownership (4) 10/02/2018 07:19:32 PM
REPR News: Statement of Changes in Beneficial Ownership (4) 10/02/2018 07:18:40 PM
REPR News: Statement of Changes in Beneficial Ownership (4) 10/02/2018 06:15:05 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#2247   third quarter earnings release date and conference call blue_skies 10/17/18 05:27:29 AM
#2246   here is a pdf put together by andy blue_skies 10/11/18 02:57:39 PM
#2245   What i am beginning to understand is that blue_skies 10/11/18 11:52:38 AM
#2244   below is a link to different methods blue_skies 10/11/18 11:13:53 AM
#2243   that is what I see. I think budge 10/11/18 10:05:48 AM
#2242   budge - was thinking about something and reread blue_skies 10/11/18 10:00:45 AM
#2241   budge - there is not much to add blue_skies 10/10/18 03:08:19 PM
#2240   new management may be a major plus here. budge 10/10/18 11:28:35 AM
#2239   budge below is a quote from a blue_skies 10/10/18 11:03:05 AM
#2238   Halozyme Theraputics. budge 10/10/18 11:00:01 AM
#2237   budge - what do you mean by "HALO"? blue_skies 10/10/18 10:32:23 AM
#2236   take a look at HALO and see if budge 10/10/18 09:30:31 AM
#2235   kush - why not go to the company blue_skies 10/10/18 09:07:44 AM
#2234   Soooo, I apparently bought a ton of shares Kushlash17 10/08/18 10:13:12 PM
#2233   new quarter new highs - works for me. blue_skies 10/01/18 10:42:38 AM
#2232   mr holty below is a quote from your post blue_skies 09/27/18 03:45:03 PM
#2231   hello mr, blue_skies 09/27/18 02:15:02 PM
#2229   I agree with much of what you wrote mrholty 09/27/18 09:25:04 AM
#2228   RMS went out and hired two highly regarded blue_skies 09/26/18 10:52:04 AM
#2227   glad to see the offer is back at blue_skies 09/26/18 10:25:41 AM
#2225   correction - was an 8k not a press release blue_skies 09/26/18 07:38:43 AM
#2224   new press release. blue_skies 09/26/18 07:03:22 AM
#2223   "holy cow batman have you seen the price blue_skies 09/20/18 10:55:53 AM
#2222   tried calling rms medical investor relations and was blue_skies 09/18/18 09:59:38 AM
#2221   link to 9/5 presentation blue_skies 09/12/18 07:07:38 PM
#2220   press release blue_skies 09/12/18 04:49:15 PM
#2219   i do not think there are a lot blue_skies 09/11/18 04:26:59 PM
#2218   If Manko keeps buying up the shares in bigpike 09/11/18 02:03:37 PM
#2217   Friday is was Manko--the filing hit just after bigpike 09/10/18 10:00:29 PM
#2216   I'm waiting to see if any filings show mrholty 09/10/18 05:12:51 PM
#2215   Can we close at 1.47? bigpike 09/10/18 03:55:36 PM
#2214   offer me some feedback on this idea?? blue_skies 09/08/18 07:16:44 PM
#2213   looks like it was Manko today..... bigpike 09/07/18 06:10:47 PM
#2212   Wow is right. mrholty 09/07/18 05:48:40 PM
#2211   Done and done. Wow. bigpike 09/07/18 03:58:54 PM
#2210   One block gone. If they want to bigpike 09/07/18 03:56:11 PM
#2209   this is like a family feud that everyone blue_skies 09/07/18 03:50:20 PM
#2208   With 20 minutes left in trading, it will bigpike 09/07/18 03:42:02 PM
#2207   the movement of the stock price suggests people blue_skies 09/07/18 03:17:21 PM
#2206   The filing appears to have motivated someone to bigpike 09/07/18 02:58:21 PM
#2205   wow - i am speechless. blue_skies 09/07/18 02:31:21 PM
#2204   The saga continues. Will 26% be enough bigpike 09/07/18 02:11:40 PM
#2203   men like donald pettigrew do not come onboard blue_skies 09/04/18 05:44:08 PM
#2202   press release blue_skies 09/04/18 05:18:01 PM
#2201   the last presentation at ld micro did blue_skies 08/28/18 10:44:03 AM
#2200   thanks, any reaction to my speculation about them taking blue_skies 08/28/18 07:48:55 AM
#2199   CHESTER, N.Y., Aug. 27, 2018 /PRNewswire/ -- Repro bigpike 08/27/18 10:25:42 PM
#2198   more speculations- This could almost be a movie. blue_skies 08/23/18 10:06:46 AM
#2197   I want to add to my speculations about blue_skies 08/20/18 12:09:55 PM
#2196   Andy's large number of shares present a problem. blue_skies 08/16/18 04:35:37 PM